The Nevada attorney general’s office is alleging that MMA fighter Kurt Holobaugh violated Nevada Athletic Commission (NAC) rules having to do with intravenous usage.
The NAC has opened a disciplinary complaint against Holobaugh and his hearing will take place Tuesday during the commission’s monthly meeting in Las Vegas, MMA Fighting confirmed Thursday. MMAjunkie was the first to report the news.
The complaint alleges that Holobaugh received more than 50 mL of fluid from an IV during a six-hour period after the weigh-ins prior to his Dana White Tuesday Night Contender Series fight with Matt Bessette in July, per NAC management analyst Nyra Phillips. The IV use was not in conjunction with medical treatment or done at a hospital and Holobaugh did not have a therapeutic use exemption (TUE), Phillips said the complaint alleges.
Under NAC rules, which are taken from the World Anti-Doping Agency (WADA), IV injections or infusions of more than 50 mL per a six-hour period are “prohibited unless the infused/injected substance is administered during a hospital admission, surgical procedure or clinical investigation.”
IV injections and infusions are prohibited in competition and out of competition by WADA, over that 50 mL in a six-hour period mark, because the practice can mask performance-enhancing drug use and aid in blood doping.
Holobaugh, 31, will go before the commission Tuesday. He’s facing a suspension and fine. Holobaugh declined to comment before the hearing when reached by MMA Fighting on Thursday.
Holobaugh (18-4) beat Bessette by first-round knockout on the card July 11, the first episode of the season. White offered Holobaugh a UFC contract following his performance on the show.
The Louisiana native has won four straight, most recently spending time with Titan FC. Holobaugh won the interim Titan lightweight title in May with a fourth-round knockout victory over Gesias Cavalcante in May.
Holobaugh fought once in the UFC, a unanimous decision loss to Steve Siler at UFC 159 in 2013.